Anti-Kallikrein-11 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the Kallikrein loop region of human Kallikrein-11 (KLK11), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Dog
UniProt
Q9UBX7
Size
100ug
Cat. #
RP2Kallikrein11

In stock

SKU
RP-Kallikrein11

Options

As low as: $130.00

Target Overview

Kallikrein-11 (KLK11, UniProt Q9UBX7) is a secreted serine protease belonging to the tissue kallikrein family, also known as hippostasin or serine protease 20. This 282-amino acid trypsin-like protease (EC 3.4.21.-) exhibits substrate specificity characteristic of kallikreins, efficiently cleaving synthetic substrates such as bz-Phe-Arg-4-methylcoumaryl-7-amide and showing preferential cleavage after arginine residues rather than lysine. KLK11 is expressed in various tissues and is synthesized as a zymogen that undergoes proteolytic processing into distinct chains. Its precise physiological substrates remain under investigation, though the enzyme's multifunctional protease activity suggests roles in extracellular matrix remodeling, growth factor activation, and potentially hormone processing. Researchers study KLK11 in the context of protease cascade regulation, epithelial biology, and tissue-specific protease networks where kallikrein family members play coordinated roles.

Background

The kallikrein family comprises fifteen serine proteases with diverse tissue distributions and regulatory functions. KLK11 was identified as a trypsin-like protease with distinct substrate preferences compared to classical tissue kallikrein. Its ability to cleave peptide bonds following arginine residues positions it within protease cascades where sequential cleavage events regulate bioactive peptide generation and protein activation. The secreted nature of KLK11 indicates involvement in extracellular proteolysis, and its expression patterns across epithelial tissues suggest participation in local regulatory networks. Recent structural and biochemical studies of trypsin-like proteases have revealed substrate binding pocket plasticity that influences specificity and inhibitor design. Tesmer et al. (2025) demonstrated nonstandard binding modes in the S1 pocket of related trypsin-like proteases, highlighting how subtle structural variations determine substrate recognition. This mechanistic insight applies broadly to kallikrein family members including KLK11, where active site architecture dictates cleavage specificity. Understanding these structural determinants informs the design of selective protease inhibitors and helps clarify individual kallikrein functions within complex proteolytic networks. Two rabbit polyclonal antibodies targeting the Kallikrein loop region are available from Triple Point Biologics, validated in human samples with predicted cross-reactivity to mouse, rat, primate, and canine orthologs. These reagents support investigations of KLK11 expression, localization, and processing in tissue sections and protein extracts across Western blot, immunohistochemistry, and immunofluorescence applications.

References

  1. Tesmer L et al (2026) Nonstandard Factor VIIa Binding Mode Reveals S1 Pocket Plasticity in Trypsin-Like Proteases. ChemMedChem. PubMed · DOI: 10.1002/cmdc.202500846

Additional Specifications

Gene Symbol KLK11
UniProt ID Q9UBX7
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Dog
Pack Size 100ug
Immunogen (Kallikrein loop)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 75-100.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 54-282.
Alternate Names KLK11, Hippostasin, Serine protease 20, Trypsin-like protease, hK11, EC 3.4.21.-

Frequently Asked Questions

What molecular weight band should I expect for KLK11 on Western blot?

Kallikrein-11 is synthesized as a 282-amino acid zymogen with a predicted molecular weight around 31 kDa. However, KLK11 undergoes proteolytic processing into distinct chains, so you may observe multiple bands depending on your sample type and the activation state of the protease. In secreted samples or conditioned media, expect the mature processed form. If you see bands above 31 kDa, consider potential glycosylation. Always include a positive control lysate from KLK11-expressing tissue to confirm the expected pattern in your experimental system.

Which tissue lysates serve as good positive controls for Kallikrein-11 antibody validation?

KLK11 is expressed in multiple tissues, with notable expression in prostate, seminal vesicle, and certain epithelial tissues based on published expression profiling. Human prostate lysate is a reliable positive control for Western blot validation. If working with conditioned media or secreted samples, consider using serum or culture supernatants from appropriate cell lines. Because KLK11 is secreted, enrichment from extracellular fractions may improve signal. Tissue distribution can be cell-type specific, so confirm expression in your model system by qPCR or proteomic databases before troubleshooting antibody performance.

What starting dilution should I use for Western blot with this KLK11 antibody?

The recommended starting dilution for Western blot is 1:1000, which works well for most human lysates with moderate KLK11 expression. If signal is weak, you can increase antibody concentration to 1:500, particularly for low-abundance samples or secreted fractions. Conversely, if background is high, try 1:2000. Because this is a rabbit polyclonal, batch-to-batch titre may vary slightly. Always optimize against your specific sample type and transfer conditions. For conditioned media or serum, you may need to concentrate samples or use more total protein to achieve detectable signal.

Does this Kallikrein-11 antibody cross-react with other kallikrein family members?

The tissue kallikrein family comprises 15 structurally related serine proteases sharing significant sequence homology, particularly in the catalytic domain. While this antibody was raised against KLK11-specific epitopes, the degree of cross-reactivity with closely related kallikreins such as KLK5, KLK7, or KLK10 has not been fully characterized in our validation. If you are working in samples with high expression of multiple kallikreins, consider running parallel experiments with recombinant proteins or validated knockdown controls to confirm specificity. Sequence alignment of the immunogen region against other family members can help predict potential cross-reactivity.

Can I use this human KLK11 antibody to detect mouse or rat Kallikrein-11?

This antibody is validated for human KLK11 detection. Mouse and rat cross-reactivity are listed as potential but not experimentally validated. Human and rodent KLK11 orthologs share approximately 70-75 percent sequence identity, so cross-reactivity is plausible depending on epitope conservation. If you need to detect rodent KLK11, test the antibody at the recommended dilution with appropriate positive control lysates from mouse prostate or seminal vesicle tissue. Include human lysate as a positive control to confirm antibody function. If signal is absent or weak, epitope divergence may limit detection in non-validated species.

How should I prepare samples to detect secreted Kallikrein-11 in conditioned media?

KLK11 is a secreted protease, so it concentrates in extracellular compartments. For conditioned media, collect serum-free medium after 24-48 hours of culture to minimize serum protease interference. Concentrate samples 10-20 fold using centrifugal filters with appropriate molecular weight cutoff before Western blot to improve detection sensitivity. Include protease inhibitors during concentration to prevent degradation, though note that serine protease inhibitors will not affect antibody binding. Load equal volumes of concentrated media rather than normalizing to cell number. For tissue lysates, fractionation to enrich secreted or extracellular matrix-associated proteins may improve signal over whole-cell lysate.

What storage conditions preserve this polyclonal KLK11 antibody long-term?

Store the antibody at -20°C for routine use. For long-term storage beyond six months, -80°C is preferable to minimize freeze-thaw degradation. Rabbit polyclonal antibodies are generally stable through multiple freeze-thaw cycles, but repeated thawing can reduce titre over time. If you use the antibody frequently, consider making single-use aliquots to avoid repeated freeze-thaw. Do not store diluted antibody; prepare fresh working dilutions in blocking buffer for each experiment. Avoid prolonged storage at 4°C, which can promote bacterial growth or aggregation. Always centrifuge briefly before use if any precipitate is visible after thawing.

Why might I see multiple bands when detecting KLK11 by Western blot?

Multiple bands are common with KLK11 because it is synthesized as a zymogen that undergoes proteolytic activation and processing. The proenzyme form is cleaved into distinct chains during activation, and you may detect both the full-length precursor and processed fragments depending on antibody epitope location. Additional bands may arise from alternative glycosylation, disulfide-linked complexes, or degradation during sample preparation. To distinguish processing from degradation, compare fresh versus aged samples and include protease inhibitors during lysis. If bands persist, the pattern may reflect authentic KLK11 biology rather than technical artifact, particularly in samples with active protease networks.

Western blot validation for RP-Kallikrein11 — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Kallikrein-11: Kallikrein loop — WB validation
WB · Panel 1 Kallikrein-11: Kallikrein loop
Kallikrein-11: Catalytic domain — WB validation
WB · Panel 2 Kallikrein-11: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • KLK11
  • Hippostasin
  • Serine protease 20
  • Trypsin-like protease
  • hK11
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →